<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/0886F2A5-22F1-47BA-8EF4-5BE4B85FD6B5"><gtr:id>0886F2A5-22F1-47BA-8EF4-5BE4B85FD6B5</gtr:id><gtr:name>University of Technology Sydney</gtr:name><gtr:address><gtr:line1>Faculty of Information Technology</gtr:line1><gtr:line2>PO Box 123 Broadway</gtr:line2><gtr:line3>NSW 2007</gtr:line3><gtr:line4>Sydney</gtr:line4><gtr:region>Outside UK</gtr:region><gtr:country>Australia</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/B1C8126F-74A6-4C31-97BA-D521464418A9"><gtr:id>B1C8126F-74A6-4C31-97BA-D521464418A9</gtr:id><gtr:name>U.S. Department of Agriculture USDA</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/1AB05DA1-4DD6-4843-B416-D7D9441EBFFB"><gtr:id>1AB05DA1-4DD6-4843-B416-D7D9441EBFFB</gtr:id><gtr:name>Royal Veterinary College</gtr:name><gtr:department>Pathology and Pathogen Biology</gtr:department><gtr:address><gtr:line1>Royal College Street</gtr:line1><gtr:line2>Camden Town</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>NW1 0TU</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/1AB05DA1-4DD6-4843-B416-D7D9441EBFFB"><gtr:id>1AB05DA1-4DD6-4843-B416-D7D9441EBFFB</gtr:id><gtr:name>Royal Veterinary College</gtr:name><gtr:address><gtr:line1>Royal College Street</gtr:line1><gtr:line2>Camden Town</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>NW1 0TU</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/AC87F8BC-3044-409A-BCD0-8E29686252CD"><gtr:id>AC87F8BC-3044-409A-BCD0-8E29686252CD</gtr:id><gtr:name>Dept for Env Food &amp; Rural Affairs  DEFRA</gtr:name><gtr:address><gtr:line1>Nobel House 17 Smith Square</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>SW1P 3RJ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>CO_FUNDER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/0886F2A5-22F1-47BA-8EF4-5BE4B85FD6B5"><gtr:id>0886F2A5-22F1-47BA-8EF4-5BE4B85FD6B5</gtr:id><gtr:name>University of Technology Sydney</gtr:name><gtr:address><gtr:line1>Faculty of Information Technology</gtr:line1><gtr:line2>PO Box 123 Broadway</gtr:line2><gtr:line3>NSW 2007</gtr:line3><gtr:line4>Sydney</gtr:line4><gtr:region>Outside UK</gtr:region><gtr:country>Australia</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/B1C8126F-74A6-4C31-97BA-D521464418A9"><gtr:id>B1C8126F-74A6-4C31-97BA-D521464418A9</gtr:id><gtr:name>U.S. Department of Agriculture USDA</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/CD1A6D95-5C9F-44A5-AB93-2606C07FB715"><gtr:id>CD1A6D95-5C9F-44A5-AB93-2606C07FB715</gtr:id><gtr:firstName>Andrew</gtr:firstName><gtr:otherNames>Nelson</gtr:otherNames><gtr:surname>Rycroft</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=BB%2FG020744%2F1"><gtr:id>1C0ADDB2-38E0-47DC-BE39-0FC71BA28D37</gtr:id><gtr:title>A multivalent vaccine and single platform diagnostic for bacterial respiratory diseases of pigs</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>BB/G020744/1</gtr:grantReference><gtr:abstractText>See main proposal.</gtr:abstractText><gtr:technicalSummary>See main proposal.</gtr:technicalSummary><gtr:fund><gtr:end>2017-03-13</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/2512EF1C-401B-4222-9869-A770D4C5FAC7"><gtr:id>2512EF1C-401B-4222-9869-A770D4C5FAC7</gtr:id><gtr:name>BBSRC</gtr:name></gtr:funder><gtr:start>2010-06-14</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>1161100</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Technology Sydney</gtr:collaboratingOrganisation><gtr:country>Australia, Commonwealth of</gtr:country><gtr:description>UTS Sydney</gtr:description><gtr:id>92757AA2-ADBB-4A2A-BE47-B41989A7DBC3</gtr:id><gtr:impact>Poster at 3rd Prato Conference.:
Raymond, B., Rohde, M., Padula, M., Maglennon, G.A. Rycroft, A.N. &amp;amp; Djordjevic, S. (2014). Proteins involved in the adherence of Mycoplasma hyopneumoniae to abiotic surfaces and porcine monolayers which may also play a role in biofilm formation. Proceedings of the 2nd Prato Conference on the Pathogenesis of Bacterial Diseases of Animals. Prato, Italy, October 2014. abs #36.</gtr:impact><gtr:outcomeId>5463639d49db74.57014285-1</gtr:outcomeId><gtr:partnerContribution>Seminar by Steve Djordjevic at RVC.
Inclusion of ANR and GAM on a poster at 3rd Prato conference on Pathogenicity of Bacteria in Animal Disease (October 2014).
Advice on microscopic techniques and stains for Alanah Deeney, PhD student by Ben Raymond.
Meetings in Sydney and Melbourne to discuss current understanding of Mycoplasma pathogenicity and future research direction. 
Discussion of possible visit to UTS by junior staff and students particularly for their microscope expertise and facility.</gtr:partnerContribution><gtr:piContribution>Hosting of a PhD student in the lab at RVC for 3 months.
Transfer of techniques for culture and mutagenesis of Mycoplasma hyopneumoniae.
Identification of genes of M. hyopneumoniae as contributing to aspects of pathogenicity and biofilm formation.
Transfer of gridded (ordered) library of 5000 transposon mutants (3000 from RVC lab) to UTS Sydney.
Contribution, as co-applicant, on a grant proposal to the Australian Research Council 2014 and 2015.
Discussions of aberrant (non-conventional) mycoplasmal respiratory disease (fibrinous pleuritis) observed in pigs and cattle.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>U.S. Department of Agriculture USDA</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>National Animal Disease Center</gtr:department><gtr:description>USDA Ames Iowa</gtr:description><gtr:id>71859B5B-1808-4AF4-B730-30316D82EE0E</gtr:id><gtr:impact>Submission of grant proposal to USDA (Agriculture and Food Research Initiative, AFRI): Tracy L Nicholson Proposal &amp;quot;US-UK Collaborative: Disease and transmission dynamics of Mycoplasma hyopneumoniae&amp;quot;. This was relient entirely upon the technological developments at RVC arising from the BBSRC LoLa grant on pig respiratory vaccination &amp;amp; diagnostics.</gtr:impact><gtr:outcomeId>54635c6a7eade9.72961202-1</gtr:outcomeId><gtr:partnerContribution>Provision of cesearean-derived, colostrum-deprived piglets for challenge studies with Streptococcus suis. Pathogenicity testing and vaccination studies with S. suis and H. parasuis in piglets.</gtr:partnerContribution><gtr:piContribution>Contribution at meeting in Ames for design of experiments for pathogenicity testing and vaccination/protection of pigs for Streptocioccus suis and Haemophilus parasuis.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs><gtr:impactSummaryOutput><gtr:description>The outcomes from this project are in progress. The project has led to new opportunities for vaccination and diagnostic techniques for pig respiratory disease which are being evaluated for development by pharmaceutical companies. Only then will the full impact of these results become manifest. 
Diagnostic methods are being exploited for the pig industry in Europe by RVC and they are being evaluated as part of a technical package by CEVA. Different novel vaccine opportunities are currently being evaluated by Zoetis. From the RVC, we have offered the option of testing, licencing and registering a live-attenuated enzootic pneumonia vaccine. From other members of the consortium (University of Cambridge) there is the opportunity to exploit results for vaccination against Streptococcus suis meningitis in the pig. Other developments arising from the findings are expected. 


Intermediate findings in the development of genetic tools for M. hyopneumoniae have allowed functional genomic analysis of the organism. The opportunity to use our data towards a novel vaccine and diagnostic system for M hyo disease are now clear. Research for this is ongoing.</gtr:description><gtr:firstYearOfImpact>2015</gtr:firstYearOfImpact><gtr:id>64738825-A02B-496D-86F8-92BED3190F88</gtr:id><gtr:impactTypes><gtr:impactType>Societal,Economic</gtr:impactType></gtr:impactTypes><gtr:outcomeId>5463abd97b93a8.92390259</gtr:outcomeId><gtr:sector>Agriculture, Food and Drink,Manufacturing, including Industrial Biotechology,Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:impactSummaryOutput></gtr:impactSummaryOutputs><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>Genetic tools have been developed for the transformation of M. hyopneumoniae and for the mutagenesis of M. hyopneumoniae to derive site-directed mutants of M. hyopneumoniae. Tools have also been developed for efficient transposon mutagenesis of M. hyopneumoniae and to design and produce candidate live-attenuated vaccines.

Abstract:
A plasmid for transforming Mycoplasma hyopneumoniae comprising an oriC region comprising both AT-rich regions from a predicted oriC region of M. hyopneumoniae 232, or comprising a variant thereof that retains the ability to act as an OriC region in M. hyopneumoniae and has at least 90% sequence identity with a sequence comprising both AT-rich regions from a predicted oriC region of M. hyopneumoniae 232.

A M. hyopneumoniae cell transformed with a plasmid of the invention may be useful in a vaccine composition. A nucleic acid construct comprising a nucleic acid sequence encoding a transposase enzyme and a promoter sequence, wherein the promoter sequence is active in M. hyopneumoniae; optionally wherein the promoter sequence comprises a promoter sequence from M. hyopneumoniae, or spiralin gene promoter of Spiroplasma citri or tetM promoter sequence from S. aureus; optionally wherein the promoter sequence from M. hyopneumoniae is a constitutively active promoter sequence, optionally a promoter sequence from the M. hyopneumoniae ldh, P97, secD, Tuf, rpoB, P146, ATP transporter ATP binding protein, Asparagine-tRNA synthetase or Translation elongation factor gene. The transposase enzyme may be a Mariner family transposase, optionally Himar1 transposase or Himar1 C9 mutant transposase.</gtr:description><gtr:grantRef>BB/G020744/1</gtr:grantRef><gtr:id>C56B40D3-CDC1-4142-83A4-CEA4EA0341D8</gtr:id><gtr:impact>Nil</gtr:impact><gtr:licensed>No</gtr:licensed><gtr:outcomeId>5463871ddbcc63.14629486</gtr:outcomeId><gtr:patentId>PCT/GB2014/051220</gtr:patentId><gtr:protection>Patent application published</gtr:protection><gtr:title>Methods for genetic manipulation of Mycoplasma hyopneumoniae.</gtr:title><gtr:yearProtectionGranted>2008</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:keyFindingsOutput><gtr:description>The project has developed new genetic techniques and tools for the manipulation of Mycoplasma hyopneumoniae. Previously, this had not been possible at all but we now have an efficient system to prepare random and site-specific mutants. This has led to the TraDIS analysis of large pools of mutants in vitro and in vivo to determine (1) the genes required for life (essential genome) and (2) those involved in survival and fitness in the body of the animal. 

Mutants lacking a key gene required for survival in the body of the pig have been identified from the functional genomic analysis. These have been isolated from our library of mutants and have been examined, using experimental infection in the pig, for safety (ability to cause pneumonia). Selected mutants have then been tested as vaccine candidates in the pig for their ability to cause an immune response to protect against experimental challenge. The most promising of these has now been transmitted to Zoetis for evaluation as a potential commercial vaccine. Other candidates have also been derived and discussions with Pharma for further evaluation and exploitation have been held. 

Substantial progress has also been made with Actinobacillus pleuropneumoniae, Haemophilus parasuis and Streptococcus suis, primarily in the laboratories of our collaborators on the grant: Langford, Maskell, Tucker &amp;amp; Wren.</gtr:description><gtr:exploitationPathways>Live attenuated vaccination of pigs against respiratory disease. Pharmaceutical companies are currently evaluating our results to determine whether they wish to exploit the findings in the development of a new generation of vaccines against pneumonia together with the diagnostic systems developed in the project.</gtr:exploitationPathways><gtr:id>3E1349BF-892A-4467-B3A4-0E724F119D18</gtr:id><gtr:outcomeId>5463aac39faef1.76595888</gtr:outcomeId><gtr:sectors><gtr:sector>Agriculture, Food and Drink,Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:sectors><gtr:url>http://www.rvc.ac.uk/about/our-people/andrew-rycroft</gtr:url></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Genetic methods and tools have been developed for the genetic transformation of M. hyopneumoniae. We have used these to demonstrate site-directed mutagenesis of M. hyopneumoniae. Tools have also been developed to derive transposon mutants of M. hyopneumoniae and to use these to design and produce candidate live-attenuated vaccines against enzootic pneumonia in the pig.</gtr:description><gtr:id>2DDBD5D7-EA74-4BB7-BC17-AE699771BA92</gtr:id><gtr:impact>Great interest from the mycoplasma research community.</gtr:impact><gtr:outcomeId>546389b3366d37.34615871</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Genetic manipulation of Mycoplasma hyopneumoniae</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2014</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>125 strains of Mycoplasma hyopneumoniae have been amassed from different geographical locations and from 1969 to 2014. These are not easy to isolate in culture. All strains have been whole genome sequenced.</gtr:description><gtr:id>69543658-1A83-442F-AA5F-96F067EE1726</gtr:id><gtr:impact>Understanding the phylogenetic structure and temporal changes in the species Mycoplasma hyopneumoniae.

Recognition of unique genes common to the species leading to research and development of diagnostic tools for the recognition of Mycoplasma hyopneumoniae and for the development of improved serological testing of pigs.

Antibiotic sensitivity profiling of strains of M hyopneumoniae and publication of this.</gtr:impact><gtr:outcomeId>54638aa0098d14.84304347</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Collection and sequencing of 125 strains of Mycoplasma hyopneumoniae.</gtr:title><gtr:type>Biological samples</gtr:type><gtr:yearFirstProvided>2013</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>9C05065E-6C92-4061-B8BB-DB10CA56966B</gtr:id><gtr:title>Use of Proteins Identified through a Functional Genomic Screen To Develop a Protein Subunit Vaccine That Provides Significant Protection against Virulent Streptococcus suis in Pigs.</gtr:title><gtr:parentPublicationTitle>Infection and immunity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/62efebcb70f1f82dc7eb0482cde2f91e"><gtr:id>62efebcb70f1f82dc7eb0482cde2f91e</gtr:id><gtr:otherNames>Brockmeier SL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0019-9567</gtr:issn><gtr:outcomeId>5aa69f0db86581.20266617</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FBA75B9B-51CE-4DBE-AC4B-CBDE3E127C6C</gtr:id><gtr:title>Characterisation of a mobilisable plasmid conferring florfenicol and chloramphenicol resistance in Actinobacillus pleuropneumoniae.</gtr:title><gtr:parentPublicationTitle>Veterinary microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/23bab64b326e5d4392de46aad85a23d4"><gtr:id>23bab64b326e5d4392de46aad85a23d4</gtr:id><gtr:otherNames>Boss? JT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0378-1135</gtr:issn><gtr:outcomeId>56df0a8f6887f4.48351856</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EFA80309-6258-47DC-B42C-5D4AE0BB6BB8</gtr:id><gtr:title>Whole genome investigation of a divergent clade of the pathogen Streptococcus suis.</gtr:title><gtr:parentPublicationTitle>Frontiers in microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/232e1d2d576604f302e1d6d9230f57c8"><gtr:id>232e1d2d576604f302e1d6d9230f57c8</gtr:id><gtr:otherNames>Baig A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1664-302X</gtr:issn><gtr:outcomeId>56df0a8e33acf5.71182721</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>21B8A8E0-AD7E-4E1E-92BF-332FF698859D</gtr:id><gtr:title>Pharmacodynamic and pharmacokinetic-pharmacodynamic modelling of anti-microbial drugs in the treatment of calf pneumonia</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/272f9daf4019e4b8b7294600631bd77c"><gtr:id>272f9daf4019e4b8b7294600631bd77c</gtr:id><gtr:otherNames>Illambas Joanna</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:outcomeId>58c6cdc8962e60.95000663</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6560F6CB-5D96-42F6-ACD5-E1182DCF546A</gtr:id><gtr:title>The use of genome wide association methods to investigate pathogenicity, population structure and serovar in Haemophilus parasuis.</gtr:title><gtr:parentPublicationTitle>BMC genomics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/edf051efb0add8489ad05c122866a892"><gtr:id>edf051efb0add8489ad05c122866a892</gtr:id><gtr:otherNames>Howell KJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1471-2164</gtr:issn><gtr:outcomeId>585d767ed9bb57.67176868</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>67D1FA0D-3BA0-42EE-83C8-FE108D9C48C6</gtr:id><gtr:title>Transposon mutagenesis in Mycoplasma hyopneumoniae using a novel mariner-based system for generating random mutations.</gtr:title><gtr:parentPublicationTitle>Veterinary research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0bd3c5d25381fa918c81bbe76a4b901c"><gtr:id>0bd3c5d25381fa918c81bbe76a4b901c</gtr:id><gtr:otherNames>Maglennon GA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0928-4249</gtr:issn><gtr:outcomeId>5675d972201ae</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E442A290-4E41-46E5-94AB-B5B988C77E66</gtr:id><gtr:title>The N-linking glycosylation system from Actinobacillus pleuropneumoniae is required for adhesion and has potential use in glycoengineering.</gtr:title><gtr:parentPublicationTitle>Open biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/42ea7ffb88b2aca6dd799ae28598e471"><gtr:id>42ea7ffb88b2aca6dd799ae28598e471</gtr:id><gtr:otherNames>Cuccui J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2046-2441</gtr:issn><gtr:outcomeId>58c6c7b9351209.83703371</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7C9786C7-D6C7-406E-9C8A-5FDE9D33B1DD</gtr:id><gtr:title>Development of genetic tools for functional genomic analysis of Mycoplasma hyopneumoniae</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/03dd82ddb5dbac8ee8607c340b8946e7"><gtr:id>03dd82ddb5dbac8ee8607c340b8946e7</gtr:id><gtr:otherNames>Cook Beth Susannah</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:outcomeId>58c6cba37c6409.98140811</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>93057366-8C94-46B9-B937-E18B557C4AB7</gtr:id><gtr:title>Development of a Multiplex PCR Assay for Rapid Molecular Serotyping of Haemophilus parasuis.</gtr:title><gtr:parentPublicationTitle>Journal of clinical microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/edf051efb0add8489ad05c122866a892"><gtr:id>edf051efb0add8489ad05c122866a892</gtr:id><gtr:otherNames>Howell KJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0095-1137</gtr:issn><gtr:outcomeId>56df0a8e55a6b8.63206808</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6B4926D2-BD0D-4573-80B8-E8B5786E15A3</gtr:id><gtr:title>Plasmid-mediated florfenicol resistance in Actinobacillus pleuropneumoniae.</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/23bab64b326e5d4392de46aad85a23d4"><gtr:id>23bab64b326e5d4392de46aad85a23d4</gtr:id><gtr:otherNames>Boss? JT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:outcomeId>546390d37c8544.46029640</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9BDDCB92-834B-4C24-9ED2-5DB1F540479A</gtr:id><gtr:title>Development of oriC containing plasmids for the transformation of M.hyopneumoniae.</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0bd3c5d25381fa918c81bbe76a4b901c"><gtr:id>0bd3c5d25381fa918c81bbe76a4b901c</gtr:id><gtr:otherNames>Maglennon GA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:outcomeId>54639326a51292.51234833</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D4CCCE61-CC00-4C0F-904C-3CB2937F2295</gtr:id><gtr:title>Development of a self-replicating plasmid system for Mycoplasma hyopneumoniae.</gtr:title><gtr:parentPublicationTitle>Veterinary research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0bd3c5d25381fa918c81bbe76a4b901c"><gtr:id>0bd3c5d25381fa918c81bbe76a4b901c</gtr:id><gtr:otherNames>Maglennon GA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0928-4249</gtr:issn><gtr:outcomeId>5675d8a042bbc</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>86FF749B-0748-4EBA-A0F3-4B3A3F718CF6</gtr:id><gtr:title>Ampicillin resistance in UK isolates of Actinobacillus pleuropneumoniae is mediated by a 4.7 kb plasmid carrying blaRob1.</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/23bab64b326e5d4392de46aad85a23d4"><gtr:id>23bab64b326e5d4392de46aad85a23d4</gtr:id><gtr:otherNames>Boss? JT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:outcomeId>54638fb15389c8.54634197</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>39E83C66-B6CD-441C-805A-8B8C19444151</gtr:id><gtr:title>Multiplex PCR assay for unequivocal differentiation of Actinobacillus pleuropneumoniae serovars 1 to 3, 5 to 8, 10, and 12.</gtr:title><gtr:parentPublicationTitle>Journal of clinical microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/23bab64b326e5d4392de46aad85a23d4"><gtr:id>23bab64b326e5d4392de46aad85a23d4</gtr:id><gtr:otherNames>Boss? JT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0095-1137</gtr:issn><gtr:outcomeId>5675da7a642e8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>06782282-A92B-47B7-88D6-0A6E349E02E3</gtr:id><gtr:title>Antimicrobial resistance profiles of Actinobacillus pleuropneumoniae isolates in the UK. #28</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/23bab64b326e5d4392de46aad85a23d4"><gtr:id>23bab64b326e5d4392de46aad85a23d4</gtr:id><gtr:otherNames>Boss? JT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:outcomeId>546392007a5505.81622361</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>83CFE4AF-ADE4-47C3-A49D-B8B3592CAA50</gtr:id><gtr:title>Whole Genome Sequencing for Surveillance of Antimicrobial Resistance in.</gtr:title><gtr:parentPublicationTitle>Frontiers in microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/23bab64b326e5d4392de46aad85a23d4"><gtr:id>23bab64b326e5d4392de46aad85a23d4</gtr:id><gtr:otherNames>Boss? JT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1664-302X</gtr:issn><gtr:outcomeId>5a2fce2f3b33a1.06501049</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8652FCF9-64C0-4243-8220-80F9560A353C</gtr:id><gtr:title>Zoonotic potential ofcarried by pet tortoises.</gtr:title><gtr:parentPublicationTitle>The Veterinary record</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f4a29ece3e8b3ed974c15eece6c47426"><gtr:id>f4a29ece3e8b3ed974c15eece6c47426</gtr:id><gtr:otherNames>Bruce HL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0042-4900</gtr:issn><gtr:outcomeId>5aa69f0d878ec5.43754457</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D3CFCAD4-3EF1-4E73-A56D-0D83D783C3BA</gtr:id><gtr:title>Minimum Inhibition concentrations of Mycoplasma hyopneumoniae Isolates from three European countries.</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8b3000035492b83e67c7925c42d3d6de"><gtr:id>8b3000035492b83e67c7925c42d3d6de</gtr:id><gtr:otherNames>Ayling RD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:outcomeId>546392ba1c2454.12248307</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4F39626B-BD74-454D-B13D-6ABBD0267F9D</gtr:id><gtr:title>Hydrogen peroxide a potential virulence factor of Mycoplasma hyopneumoniae.</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e001a95c43982455cda43def7f07fa99"><gtr:id>e001a95c43982455cda43def7f07fa99</gtr:id><gtr:otherNames>Deeney AS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:outcomeId>54638dcbbb2239.87290814</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C7298E9E-F236-419F-8CF3-DB604E280633</gtr:id><gtr:title>Selective medium for culture of Mycoplasma hyopneumoniae.</gtr:title><gtr:parentPublicationTitle>Veterinary microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/72b3e5778a1a77daf358e1c5fbd3fc58"><gtr:id>72b3e5778a1a77daf358e1c5fbd3fc58</gtr:id><gtr:otherNames>Cook BS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0378-1135</gtr:issn><gtr:outcomeId>58c6bdb369fc36.88007196</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E84D2706-D2AE-455A-8974-70BA62ECCB13</gtr:id><gtr:title>Actinobacillus pleuropneumoniae serovar 8 predominates in England and Wales.</gtr:title><gtr:parentPublicationTitle>The Veterinary record</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bd75dbe105014309cbdded985198a393"><gtr:id>bd75dbe105014309cbdded985198a393</gtr:id><gtr:otherNames>Li Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0042-4900</gtr:issn><gtr:outcomeId>585d3dbba9cf62.99855700</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>73C36AC0-5DD0-4531-8866-B7D830D552DF</gtr:id><gtr:title>Mutants in the Mycoplasma hyopneumoniae strain 232 mnuA gene generated by targeted disruption and transposon mutagenesis exhibit significant reductions in nuclease activity.</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0bd3c5d25381fa918c81bbe76a4b901c"><gtr:id>0bd3c5d25381fa918c81bbe76a4b901c</gtr:id><gtr:otherNames>Maglennon GA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:outcomeId>54638c2f3396b8.05660803</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>96C3BEF1-8F53-4021-B22A-72EBC8CD9080</gtr:id><gtr:title>Identification of PluMu: a Mu-like bacteriophage infecting Actinobacillus pleuropneumoniae.</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/deabbc1c8f2aa654cff4b74d594fa522"><gtr:id>deabbc1c8f2aa654cff4b74d594fa522</gtr:id><gtr:otherNames>Fernandez Crespo R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:outcomeId>54638d24a43764.36165630</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2E98A188-998F-4119-BDE6-A4CFE4271100</gtr:id><gtr:title>Patterns of antimicrobial resistance in Streptococcus suis isolates from pigs with or without streptococcal disease in England between 2009 and 2014.</gtr:title><gtr:parentPublicationTitle>Veterinary microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3efba8cfcc158dfd3d95941f60ea870f"><gtr:id>3efba8cfcc158dfd3d95941f60ea870f</gtr:id><gtr:otherNames>Hernandez-Garcia J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0378-1135</gtr:issn><gtr:outcomeId>5aa69f0de2c982.01852744</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>81A9C77D-E813-400A-929B-40D29E5D000C</gtr:id><gtr:title>An investigation of novel therapeutic and prophylactic tools for Streptococcus suis</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/429832ffa5493f8372f914adedb6f6fd"><gtr:id>429832ffa5493f8372f914adedb6f6fd</gtr:id><gtr:otherNames>Fletcher Michael John</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:outcomeId>58c6ccc5d2d443.47079625</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F5906AB2-CC1F-4263-80F4-3080962A8926</gtr:id><gtr:title>Identification of dfrA14 in two distinct plasmids conferring trimethoprim resistance in Actinobacillus pleuropneumoniae.</gtr:title><gtr:parentPublicationTitle>The Journal of antimicrobial chemotherapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/23bab64b326e5d4392de46aad85a23d4"><gtr:id>23bab64b326e5d4392de46aad85a23d4</gtr:id><gtr:otherNames>Boss? JT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0305-7453</gtr:issn><gtr:outcomeId>5675e4232c878</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E8FB1D58-DB67-4365-9036-D872FAE68660</gtr:id><gtr:title>Erratum: Genomic signatures of human and animal disease in the zoonotic pathogen Streptococcus suis.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/464a69d208034edf889526a6f84cdb83"><gtr:id>464a69d208034edf889526a6f84cdb83</gtr:id><gtr:otherNames>Weinert LA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>56df0a8f1f08c1.83853452</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F0D1E17D-B13F-40FF-B33F-F04EF0ED5900</gtr:id><gtr:title>ICEApl1, an Integrative Conjugative Element Related to ICEHin1056, Identified in the Pig Pathogen Actinobacillus pleuropneumoniae.</gtr:title><gtr:parentPublicationTitle>Frontiers in microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/23bab64b326e5d4392de46aad85a23d4"><gtr:id>23bab64b326e5d4392de46aad85a23d4</gtr:id><gtr:otherNames>Boss? JT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1664-302X</gtr:issn><gtr:outcomeId>585d3e3a8d55b7.53137367</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4B06BBB9-7897-47AD-A384-666266DEE05C</gtr:id><gtr:title>Necrosis from needlestick injury with live Actinobacillus pleuropneumoniae porcine vaccine.</gtr:title><gtr:parentPublicationTitle>BMJ (Clinical research ed.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8bbcf5d0da86d140ce2beb31d185f265"><gtr:id>8bbcf5d0da86d140ce2beb31d185f265</gtr:id><gtr:otherNames>Rycroft AN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0959-535X</gtr:issn><gtr:outcomeId>5453a992111bb9.27919708</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BCBC37ED-F6C3-4297-B099-A7F677B9657E</gtr:id><gtr:title>Complete Genome Sequence of MIDG2331, a Genetically Tractable Serovar 8 Clinical Isolate of Actinobacillus pleuropneumoniae.</gtr:title><gtr:parentPublicationTitle>Genome announcements</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/23bab64b326e5d4392de46aad85a23d4"><gtr:id>23bab64b326e5d4392de46aad85a23d4</gtr:id><gtr:otherNames>Boss? JT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>56df0a8e126507.76437335</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AE854DB7-9C8C-42E5-A928-81F9A80AA194</gtr:id><gtr:title>Generation of a Tn5 transposon library in Haemophilus parasuis and analysis by transposon-directed insertion-site sequencing (TraDIS).</gtr:title><gtr:parentPublicationTitle>Veterinary microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ebabee70b0e2fa5c626ca468cb266257"><gtr:id>ebabee70b0e2fa5c626ca468cb266257</gtr:id><gtr:otherNames>Luan SL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0378-1135</gtr:issn><gtr:outcomeId>5675d8acbfffe</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3FC0F65C-3DFC-49FD-9889-596E84387C8D</gtr:id><gtr:title>&amp;quot;Pathotyping&amp;quot; Multiplex PCR Assay for Haemophilus parasuis: a Tool for Prediction of Virulence.</gtr:title><gtr:parentPublicationTitle>Journal of clinical microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/edf051efb0add8489ad05c122866a892"><gtr:id>edf051efb0add8489ad05c122866a892</gtr:id><gtr:otherNames>Howell KJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0095-1137</gtr:issn><gtr:outcomeId>5a35f8a53d6e03.49294970</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FA163411-F368-4DAA-88D6-5ECB26A50243</gtr:id><gtr:title>The generation of successive unmarked mutations and chromosomal insertion of heterologous genes in Actinobacillus pleuropneumoniae using natural transformation.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/23bab64b326e5d4392de46aad85a23d4"><gtr:id>23bab64b326e5d4392de46aad85a23d4</gtr:id><gtr:otherNames>Boss? JT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>doi_55f94b94bd296414</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2B652979-7E1F-46B2-8F63-67F7ED515B5C</gtr:id><gtr:title>Pharmacokinetics and pharmacodynamics of antimicrobial drugs used in the treatment of calf pneumonia</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aa418658a95388b52b1bf7de3f5ac446"><gtr:id>aa418658a95388b52b1bf7de3f5ac446</gtr:id><gtr:otherNames>Potter Timothy</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:outcomeId>58c6ce11803e36.04816533</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C575E235-A756-469D-87D7-34ED5D5CE18C</gtr:id><gtr:title>Identification of dfrA14 in two distinct plasmids conferring trimethoprim resistance in Actinobacillus pleuropneumoniae.</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/23bab64b326e5d4392de46aad85a23d4"><gtr:id>23bab64b326e5d4392de46aad85a23d4</gtr:id><gtr:otherNames>Boss? JT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:outcomeId>54639156cac4f2.92708271</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8B537EDA-105C-4E9A-A83E-4CDF71A634DF</gtr:id><gtr:title>In vivo testing of novel vaccine prototypes against Actinobacillus pleuropneumoniae.</gtr:title><gtr:parentPublicationTitle>Veterinary research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/62bbc25410578bdd39f6b567ee8dc269"><gtr:id>62bbc25410578bdd39f6b567ee8dc269</gtr:id><gtr:otherNames>Antenucci F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0928-4249</gtr:issn><gtr:outcomeId>5aa9167a630836.92640358</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C06C8A63-8378-4165-BA89-5E28A8A42D58</gtr:id><gtr:title>A multiplex PCR to differentiate Actinobacillus pleuropneumoniae serovar 1-3, 5-8, 10 and 12 isolates.</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/23bab64b326e5d4392de46aad85a23d4"><gtr:id>23bab64b326e5d4392de46aad85a23d4</gtr:id><gtr:otherNames>Boss? JT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:outcomeId>546390483c9423.14415842</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5E81A98A-B16E-4928-BB3B-2DA4EC5A11A3</gtr:id><gtr:title>Genomic signatures of human and animal disease in the zoonotic pathogen Streptococcus suis.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/464a69d208034edf889526a6f84cdb83"><gtr:id>464a69d208034edf889526a6f84cdb83</gtr:id><gtr:otherNames>Weinert LA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>5675e18921317</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9FC1C72C-600B-478D-BE3C-8CF5D9D194CA</gtr:id><gtr:title>Survival of Actinobacillus pleuropneumoniae outside the pig.</gtr:title><gtr:parentPublicationTitle>Research in veterinary science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1fe0088b441eb4ef942c795657ab0c37"><gtr:id>1fe0088b441eb4ef942c795657ab0c37</gtr:id><gtr:otherNames>Assavacheep P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0034-5288</gtr:issn><gtr:outcomeId>5453a6b89abda5.43514822</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F510F634-AA6F-40DB-A029-E76BEA310230</gtr:id><gtr:title>A Unique Capsule Locus in the Newly Designated Actinobacillus pleuropneumoniae Serovar 16 and Development of a Diagnostic PCR Assay.</gtr:title><gtr:parentPublicationTitle>Journal of clinical microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/23bab64b326e5d4392de46aad85a23d4"><gtr:id>23bab64b326e5d4392de46aad85a23d4</gtr:id><gtr:otherNames>Boss? JT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0095-1137</gtr:issn><gtr:outcomeId>58c6c84e4bb407.03793077</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>14097677-93C4-415D-8B7F-BBA272CF9C79</gtr:id><gtr:title>Gene content and diversity of the loci encoding biosynthesis of capsular polysaccharides of the 15 serovar reference strains of Haemophilus parasuis.</gtr:title><gtr:parentPublicationTitle>Journal of bacteriology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/edf051efb0add8489ad05c122866a892"><gtr:id>edf051efb0add8489ad05c122866a892</gtr:id><gtr:otherNames>Howell KJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0021-9193</gtr:issn><gtr:outcomeId>54528eea3f3801.83973437</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">BB/G020744/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>